新股消息 | 中通快遞擬明日在港招股,入場費13535港元
據《香港經濟日報》報道,中通快遞擬明日在港招股,將成爲第六家在港二次上市的中概股。
此前已經在港二次上市的有:阿裏巴巴、網易、京東、百勝中國、華住集團(正在招股)。
根據美國證券交易委員會文件,中通快遞在香港第二上市的集資額不超過15.6億美元(約121億港元),將出售4500萬股,香港公開發售的最高定價爲268港元,每手50股,入場費13535港元,並於9月22日定價,9月29日掛牌。
中通快遞昨日美股收報31.37美元,約243.1港元,即港股最高定價較美股昨日收市價溢價約10%。
高盛爲中通快遞獨家保薦人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.